06 · Service
Oncology Programs
A dedicated, fully segregated facility purpose-built for anti-neoplastic and high-potency formulations — covering both oral solid dosage forms and injectables.
DRAG TO ROTATE
Capability
- Cytotoxic and HPAPI-ready containment
- Oral solid dosage forms (tablets, capsules)
- Injectables — solutions, suspensions, lyophilized
Segregation
- Physically and operationally separated from general operations
- Dedicated equipment train end-to-end
- Containment-compliant air handling and effluent management
Related services
Explore the rest of the lifecycle.
Formulation
QbD-driven formulation of oral solids and liquids — from pre-formulation through prototype to scale-up readiness.
Injectables
Sterile and non-sterile injectable formulation — solutions, suspensions, lyophilized products, and peptides.
Analytical
Method development, validation, stability, and routine QC analysis to US FDA / EU EMA standards.